Literature DB >> 16991168

Hierarchical mechanochemical switches in angiostatin.

Fabio Grandi1, Massimo Sandal, Giovanni Guarguaglini, Emidio Capriotti, Rita Casadio, Bruno Samorì.   

Abstract

We wish to propose a novel mechanism by which the triggering of a biochemical signal can be controlled by the hierarchical coupling between a protein redox equilibrium and an external mechanical force. We have characterized this mechanochemical mechanism in angiostatin, and we have evidence that it can switch the access to partially unfolded structures of this protein. We have identified a metastable intermediate that is specifically accessible under thioredoxin-rich reducing conditions, like those met by angiostatin on the surface of a tumor cell. The structure of the same intermediate accounts for the unexplained antiangiogenic activity of angiostatin. These findings demonstrate a new link between redox biology and mechanically regulated processes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16991168     DOI: 10.1002/cbic.200600227

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  5 in total

1.  Theory of long distance interaction between antibodies and antigens.

Authors:  Udo Riss
Journal:  Eur Biophys J       Date:  2011-06-30       Impact factor: 1.733

2.  Mechanochemistry: one bond at a time.

Authors:  Jian Liang; Julio M Fernández
Journal:  ACS Nano       Date:  2009-07-02       Impact factor: 15.881

3.  Structure and function of a fungal adhesin that binds heparin and mimics thrombospondin-1 by blocking T cell activation and effector function.

Authors:  T Tristan Brandhorst; René Roy; Marcel Wüthrich; Som Nanjappa; Hanna Filutowicz; Kevin Galles; Marco Tonelli; Darrell R McCaslin; Kenneth Satyshur; Bruce Klein
Journal:  PLoS Pathog       Date:  2013-07-11       Impact factor: 6.823

4.  Conformational equilibria in monomeric alpha-synuclein at the single-molecule level.

Authors:  Massimo Sandal; Francesco Valle; Isabella Tessari; Stefano Mammi; Elisabetta Bergantino; Francesco Musiani; Marco Brucale; Luigi Bubacco; Bruno Samorì
Journal:  PLoS Biol       Date:  2008-01       Impact factor: 8.029

Review 5.  A Combination of Immune Checkpoint Inhibition with Metronomic Chemotherapy as a Way of Targeting Therapy-Resistant Cancer Cells.

Authors:  Irina Kareva
Journal:  Int J Mol Sci       Date:  2017-10-13       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.